Pike MC - Search Results

1

A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase.

Makridakis N, Ross RK, Pike MC, Chang L, Stanczyk FZ, Kolonel LN, Shi CY, Yu MC, Henderson BE, Reichardt JK. Makridakis N, et al. Among authors: pike mc. Cancer Res. 1997 Mar 15;57(6):1020-2. Cancer Res. 1997. PMID: 9067262

2

5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males.

Ross RK, Bernstein L, Lobo RA, Shimizu H, Stanczyk FZ, Pike MC, Henderson BE. Ross RK, et al. Among authors: pike mc. Lancet. 1992 Apr 11;339(8798):887-9. doi: 10.1016/0140-6736(92)90927-u. Lancet. 1992. PMID: 1348296

3

From gene to carcinogen: a rapidly evolving field in molecular epidemiology.

Jones PA, Buckley JD, Henderson BE, Ross RK, Pike MC. Jones PA, et al. Among authors: pike mc. Cancer Res. 1991 Jul 1;51(13):3617-20. Cancer Res. 1991. PMID: 2054797

4

Personal and family history of lung disease as risk factors for adenocarcinoma of the lung.

Wu AH, Yu MC, Thomas DC, Pike MC, Henderson BE. Wu AH, et al. Among authors: pike mc. Cancer Res. 1988 Dec 15;48(24 Pt 1):7279-84. Cancer Res. 1988. PMID: 3191498

5

Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk.

Reichardt JK, Makridakis N, Henderson BE, Yu MC, Pike MC, Ross RK. Reichardt JK, et al. Among authors: pike mc. Cancer Res. 1995 Sep 15;55(18):3973-5. Cancer Res. 1995. PMID: 7664265

6

Genetic variation of 3 beta-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: implications for prostate cancer risk.

Devgan SA, Henderson BE, Yu MC, Shi CY, Pike MC, Ross RK, Reichardt JK. Devgan SA, et al. Among authors: pike mc. Prostate. 1997 Sep 15;33(1):9-12. doi: 10.1002/(sici)1097-0045(19970915)33:1<9::aid-pros2>3.0.co;2-h. Prostate. 1997. PMID: 9294620

7

Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations.

Feigelson HS, Shames LS, Pike MC, Coetzee GA, Stanczyk FZ, Henderson BE. Feigelson HS, et al. Among authors: pike mc. Cancer Res. 1998 Feb 15;58(4):585-7. Cancer Res. 1998. PMID: 9485002 Free article.

8

The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels.

Cote RJ, Skinner EC, Salem CE, Mertes SJ, Stanczyk FZ, Henderson BE, Pike MC, Ross RK. Cote RJ, et al. Among authors: pike mc. Br J Cancer. 1998 Aug;78(3):413-8. doi: 10.1038/bjc.1998.508. Br J Cancer. 1998. PMID: 9703292 Free PMC article. Clinical Trial.

9

Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility.

Ross RK, Pike MC, Coetzee GA, Reichardt JK, Yu MC, Feigelson H, Stanczyk FZ, Kolonel LN, Henderson BE. Ross RK, et al. Among authors: pike mc. Cancer Res. 1998 Oct 15;58(20):4497-504. Cancer Res. 1998. PMID: 9788589 Review.

10

Cytochrome P450c17alpha gene (CYP17) polymorphism predicts use of hormone replacement therapy.

Feigelson HS, McKean-Cowdin R, Pike MC, Coetzee GA, Kolonel LN, Nomura AM, Le Marchand L, Henderson BE. Feigelson HS, et al. Among authors: pike mc. Cancer Res. 1999 Aug 15;59(16):3908-10. Cancer Res. 1999. PMID: 10463580

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

636 results

Search Page

Filters